BACKGROUND: Between 2007 and 2013, the Tanzanian public sector received 93.1 million doses of first-line anti-malarial artemisinin-based combination therapy (ACT) in the form of artemether-lumefantrine entirely supplied by funding partners.
This paper presents the results of a qualitative study to investigate the perceptions and experiences of health workers involved in a a cluster-randomized controlled trial of a novel intervention to improve health worker malaria case-management in 107 government health facilities in Kenya.
mHealth Evidence is expanding to include grey literature in the growing body of evidence.
Registered users of mHealth Evidence may now use this bookmarklet feature to contribute material for submission. Please note contributors must be logged in to access this feature. All submissions will be reviewed.